Lepu Medical Technology (Beijing) Co., Ltd. (hereinafter referred to as "Lepu Medical") was founded in 1999 and is one of the earliest enterprises in China engaged in the research and development and manufacturing of cardiac interventional medical devices. For over 20 years, the company has focused on providing comprehensive services for cardiovascular disease patients, driven by innovation for high-quality development. It has now become a leading cardiovascular health industry platform in China, with its main business covering three major sectors: medical devices, pharmaceuticals, and medical services and health management. It has been awarded the title of "National Engineering Technology Research Center for Interventional Devices and Equipment for Heart Disease" by the Ministry of Science and Technology. The company’s independently developed products, including bioabsorbable stents, cutting balloons, drug-coated balloons, degradable occluders, TAVR valves, and artificial intelligence ECG automatic analysis and diagnosis systems, have reached an internationally advanced level. In the future, Lepu Medical will continue to uphold its original intention of "serving cardiovascular disease patients wholeheartedly" and will continuously provide a full lifecycle service for disease prevention, diagnosis, drug treatment, surgical treatment, postoperative rehabilitation, chronic disease management, and re-prevention. The company will also increase its investment in technological innovation and actively layout strategic emerging industries such as AI medical technology, while striving to provide advanced and high-quality products and services for patients and continuously promoting technological progress and industrial enhancement in the industry.